raised from Roche Children’s Walk 2021
samplings planted under China’s “Million Tree Planting Project”
women in leadership team
chest pain centres in top hospitals adopted improved workflow for heart failure diagnosis
healthcare professionals educated in use of tumour marker tests
Medical infrastructure and disease prevention have been China’s healthcare focuses since 2019, to counter the growing incidence of chronic diseases related to lifestyle habits.
A positive effect of the coronavirus on China’s health industry was the improvement of in-vitro diagnostics development, with many local manufactures launching nucleic acid tests, serology tests, and point-of-care tests.
Roche played an integral role in helping China understand how diagnostics could be the first line of defense against infections, and supported multiple stakeholders, from the authorities to labs and healthcare providers, to trial testing solutions and conduct epidemiologic investigations around the virus to better shape China’s pandemic containment strategy.
Using research to battle COVID-19
Reducing wait time with for heart attack patients with MyLab+ER
Promoting safer lung cancer treatment with Tumor Marker Tests